Tuesday, September 16, 2025

New drug could be first to stop deadly fatty liver disease

Scientists at UC San Diego have identified a new drug, ION224, that could transform the treatment of MASH, a dangerous form of fatty liver disease tied to obesity and diabetes. By blocking a key liver enzyme, the drug reduces fat and inflammation, halting the root causes of liver damage. In a year-long clinical trial, patients showed major improvements without serious side effects, offering hope to millions affected worldwide.

from Top Health News -- ScienceDaily https://ift.tt/EWrhg8U
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

This “master gene” may be driving pancreatic cancer’s spread

A gene called KLF5 may be a key force behind the spread of pancreatic cancer—but not in the way scientists expected. Rather than mutating DN...